Navigation Links
Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development
Date:7/15/2010

pported with federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), under Contract No. HHSO100201000026C, and the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH), the Department of Health and Human Services (HHS) and BARDA under Contract No. HHSN272200700035C.

About Elusys Therapeutics

Elusys Therapeutics, a private company based in Pine Brook, NJ, is focused on the development of antibody therapeutics for the treatment of life-threatening disease. Elusys has been engaged in development of biodefense countermeasures since 2000. The company has established experience in government contract management and to date has received multiple grants and contracts totally up to $177 million in government funding.  Anthim, a highly effective anthrax anti-toxin, is in late-stage development and is a strong candidate for future procurement into the Strategic National Stockpile.  For more information, please visit www.elusys.com.

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers' needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the
'/>"/>

SOURCE Elusys Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
2. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
3. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)...  The acceptance of two abstracts on the ... demonstrates continued interest in the Eclipse System, the ... of the abstracts, presented by Catherine Matthews ... Urogynecology and Reconstructive Pelvic Surgery at the University ... Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... Nov. 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) ... election of Anthony J. Cataldo as Chief Executive ... Effective November 19, 2014, Ken Eaton resigned his ... of Directors of Oxis International, Inc. to pursue new opportunities. ... named Chief Executive Officer of Oxis International, Inc. Mr. Cataldo ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... announced it has received FDA clearance for the TM-S ... is the industry,s first cervical interbody device incorporating porous metal ... for cervical interbody fusion (IBF) in the United States. ...
... CARLSBAD, Calif., Feb. 18, 2011 Life Technologies Corporation ... Angel Carracedo and Dr. Mark Pallen as the winners of ... Grants Program.   (Logo:   http://photos.prnewswire.com/prnh/20110216/MM49339LOGO ) ... because of the ubiquitous nature of the Ion Torrent sequencing ...
Cached Medicine Technology:Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 2Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 4Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 5
(Date:11/22/2014)... (PRWEB) November 22, 2014 Hastings and ... decades of experience announces providing clients with the option ... firm offers clients a flexible, intuitive and easy to ... with having access to Google + allows clients to ... to make a more informed decision when retaining an ...
(Date:11/22/2014)... FL (PRWEB) November 22, 2014 ... Innovations are pleased to announce that Ashley Lombardo ... Thanksgiving #PayItForward contest. , Ms. Lombardo entered friend ... Kitchen Innovations. She wrote of how her friend is ... daughters as a single mom. Despite medical bills piling ...
(Date:11/22/2014)... Boulder, CO (PRWEB) November 22, 2014 ... on growth equity investments in the consumer brand ... LLC. The investment will be used to help ... new product pipeline rollout, particularly its proprietary apparel ... Suslow will join BackJoy’s Board of Directors. , ...
(Date:11/22/2014)... Aliso Viejo, California (PRWEB) November 22, 2014 ... have announced a new plugin entitled FCPX 3D Model bringing ... , “FCPX 3D Model allows users to add obj files ... of Pixel Film Studios. “Blurring the line between professional and ... FCPX3D Model from Pixel Film Studios allows Final Cut Pro ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... Inc. (Nasdaq: LMAT ) announced today that it ... 30, 2008, after the close of the,market. In conjunction ... same day at 5:00 PM ET. The call will ... listen to the live webcast at, http://www.lemaitre.com/investor, or ...
... 18 Dr. James B.,Peake, the Secretary of ... open a unique vocational counseling center for disabled,veterans., ... this center is yet,another partnership that recognizes the ... and access to resources to veterans sets,the stage ...
... BlueCross BlueShield of South,Carolina today announced that Greenville businesswoman ... A native of Elberton, Ga., Shaw now lives ... Corp., a family investment corporation.,She previously worked for C ... National,Bank of South Carolina, and Manly Investment Group in ...
... destination for quality skincare,will debut three new locations ... SEATTLE, April 18 Calidora Skin Clinic, ... its doors,in Southern California this April. The three ... Monica - will offer Southern Californians the,chance to ...
... been proved, one expert says , , FRIDAY, April 18 (HealthDay ... severe psoriasis appears to be safe and effective, a Canadian ... which is a calcineurin inhibitor, significantly improve symptoms of psoriasis. ... is the first oral medication in 20 years to show ...
... (OTC,Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of ... has,changed to CHRX from PMQC. The Company,s common stock ... About Chem Rx Corporation, Founded more than ... of institutional pharmacy services in the New York City,metropolitan ...
Cached Medicine News:Health News:Disabled Counseling Center Comes to Twin Cities 2Health News:Shaw Elected to S.C. BlueCross BlueShield Board 2Health News:Upscale Seattle-Based Skincare Clinic Expands Into California With Unique Custom Tailored Skincare Approach 2Health News:New Psoriasis Pill Appears Effective 2Health News:New Psoriasis Pill Appears Effective 3Health News:Chem Rx Corporation Changes Ticker Symbol to CHRX 2
Replacement bulb for Vibratome light system....
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
Medicine Products: